Fact CheckerSign in

NCT07459595Not yet recruitingPhase 1

Metformin Versus Myo-inositol in the Management of Polycystic Ovarian Disease: A Comparative Study

Source: ClinicalTrials.gov · Last updated 10 Mar 2026

Brief summary (registry, in English)

In polycystic ovary syndrome (PCOS), changes in physical appearance i.e. weight gain, hirsutism, menstrual disturbances and infertility result in reduced quality-of-life. PCOS is one of the most common endocrine disorders affecting about 4% to 8% of women of reproductive age. Diagnosis is primarily clinical with Rotterdam criteria being the most commonly followed criteria, which require the presence of two out of the three criteria including oligo and/or anovulation, clinical and/or biochemical signs of hyperandrogenism and polycystic ovaries on ultrasound. The objective of this study is to compare the outcome of Metformin versus Myo-inositol in the management of polycystic ovarian disease.

Status (registry)
Not yet recruiting
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
60 (estimated)
First submitted
5 Mar 2026
Start date
1 May 2026
Primary completion date
31 Jul 2026
Lead sponsor
Fatima Tariq
NCT number
NCT07459595

What you commit to

  • Study type: Interventional · Phase 1
  • Planned participants: 60
  • From 1 May 2026 to the primary completion date, 31 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Females already taking trial drugs

Other illness

  • Females allergic to any content of trial drugs (on history)

Lab values

  • Females with chronic diabetes (BSR\>200 mg/dl), hypertension (BP≥140/90mmHg)

Other

  • Females already taken or taking PCOS treatment (on medical record)
  • Females already enrolled in another trial program
  • Females with PCOS along with gestational sac (on ultrasound)

Who the study is looking for

  • Married or unmarried
  • Diagnosed with PCOS (females presenting with compliant of irregular cycle for \>3 months, with hirsutism, acne, presence of polycystic ovaries detected on ultrasound ).

Age in the registry: 16 years to 45 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CMH Gujranwala
Coordinator of this site? Confirm its status
Chak One Hundred Seventy-five Nine LeftPakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.